Breaking News on Pharmaceutical Technology

Product news > Drug delivery systems

Latest news headlines

Products

Suppliers

UPDATE

Drug delivery researchers must focus on carrier shape, says new study

08-Dec-2011 - Drug delivery developers need more focus on the shape of the carrier, rather than the size and surface chemistry, according to a new study.

Gel that releases drugs in vivo could replace implants, say researchers

07-Dec-2011 - An injectable gel that releases drugs when triggered by an AA battery powered electric field could replace implants, say researchers.

News in brief

Ampio buys ODT tech for to accelerate ED drug development

06-Dec-2011 - US developer Ampio Pharmaceuticals says new orally disintegrating tablet (ODT) tech will boost market acceptance of its premature ejaculation rug.

Patents, legal battles and R&D dominate drug delivery headlines

05-Dec-2011 - Legal battles, patent acquisitions and R&D dominate in-pharmatechnologist.com’s round up of developments in drug delivery this week with news from MonoSol, Acacia and a US University team working on GSK’s Relenza.

Drug delivery research round-up

28-Nov-2011 - in-PharmaTechnologist presents its round-up of the latest drug delivery research developments in the pharmaceutical world, including tumour targeting peptides and lipid nanoparticle drug-delivery technology.

Biocon close to finalising partnership for development of oral insulin

24-Nov-2011 - Biocon is close to signing an agreement with a partner willing to inject cash into its experimental insulin pill, said its MD.

pSivida signs tech evaluation agreement for injectable implant

23-Nov-2011 - pSivida has inked a technology evaluation agreement with an unnamed global pharma over its Durasert drug delivery technology.

GSK urges FDA to consider absorption of nanomaterials in new guidance

23-Nov-2011 - GlaxoSmithKline (GSK) has urged the US FDA consider the absorption of nanomaterials in the gastrointestinal (GI) tract within its proposal for new regulations on nanotechnology.

FDA nanomaterial draft guidance means pointless extra regulation, say experts

22-Nov-2011 - FDA draft guidance defines nanoparticles too broadly and could result in APIs being categorised as nanomaterials, industry said.

Gold nanoparticles can cut blood supply to tumours, say researchers

21-Nov-2011 - Gold nanoparticles can target endothelial cells to cut the supply of oxygen to most types of tumour, according to a new study.

Pharma must improve existing methods to boost solubility as “quantum leap” unlikely

15-Nov-2011 - To boost solubility pharma must develop, refine and improve existing methods as a “quantum leap” in formulation is unlikely, Pharmaterials' CEO said.

Mylan to buy Pfizer's respiratory delivery platform

10-Nov-2011 - Pfizer will sell Mylan its dry-powder inhaler delivery system in an agreement set to pit the generics firm against UK drug major GlaxoSmithKline (GSK).

Pfizer & Bend collaborating on osteoarthritis nanoparticle drug delivery

03-Nov-2011 - Bend Research is developing a nanoparticle drug delivery system for treating osteoarthritis in a “close collaboration” with Pfizer.

Evonik to buy SurModics’ drug delivery assets and cGMP plant

02-Nov-2011 - SurModics is selling its drug delivery assets and cGMP manufacturing facility to Evonik for $30m (€22m) in cash.

Electro capsule means researchers can 'see' drug release in vivo, says Medimetrics and Bio-Images

31-Oct-2011 - Medimetrics is collaborating with Bio-Images to offer its electronic targeted drug delivery tech to clinical researchers.

Round-up of news & views from AAPS & CPhI 2011

31-Oct-2011 - In-PharmaTechnologist presents a roundup of news and views shared by exhibitors and attendees at AAPS and CPhI.

Delivery vehicles can revitalise RNAi sector; AAPS panel

31-Oct-2011 - Aptamers and dendrimers can revitalise the faltering siRNA sector by solving delivery problems, AAPS panelists said.

Drug delivery devices could be powered by the body, say researchers

18-Oct-2011 - A device developed at the Joseph Fourier University could be used to power drug delivery technologies and medical implants using energy created in vivo within the next decade, say researchers.

Medgenics confirms talks with Baxter on biopump deal

17-Oct-2011 - Tissue-based delivery tech developer Medgenics is in talks with Baxter Healthcare about new deal, but says continued focus on Factor VIII is not ‘mission critical’ to biopump platform.

Drug shortages drive demand surge & expansion at Akorn

10-Oct-2011 - Akorn is doubling capacity and hiring “as fast as [it] can” after drug shortages sent demand for its injectables soaring.

Melanoma therapy costs could be slashed thanks to new device, says OncoSec

06-Oct-2011 - The price of melanoma therapy could soon be slashed thanks to a new delivery system developed by US firm OncoSec.

Insulin pens & Brazil buy drive Gerresheimer growth

06-Oct-2011 - Gerresheimer posted a jump in sales and upgraded guidance on strong demand for insulin pens and the Vedat acquisition.

Bespak's nasal delivery device wins firm second development deal

04-Oct-2011 - Bespak has won its second nasal delivery device development deal in as many months for a major global manufacturer of generic medicines.

Intercell hopeful for future of needle-free vaccine

29-Sep-2011 - Intercell is seeking new partnerships for its struggling needle-free patch system for delivering vaccines.

Unigene cuts SDBG to focus gaze on peptides

27-Sep-2011 - Peptide-based therapeutics specialists Unigene will focus on high valuation drug development and drug delivery opportunities after cutting loose its Site Directed Bone Growth (SDBG) patent portfolio.

Sign up for your free newsletter